Literature DB >> 28548487

The Challenge of Overcoming Antibiotic Resistance: An Adjuvant Approach?

Roberta J Melander1, Christian Melander1.   

Abstract

Antibiotic resistance is one of the greatest current threats to human health, and without significant action we face the chilling prospect of a world without effective antibiotics. Although continued effort toward the development of new antibiotics, particularly those with novel mechanisms of action, remains crucial, this alone probably will not be enough to prevail, and it is imperative that additional approaches are also explored. One such approach is the identification of adjuvants that augment the activity of current antibiotics. This approach has the potential to render an antibiotic against which bacteria have developed resistance once again effective, to broaden the spectrum of an antibiotic, and to lower the required dose of an antibiotic. In this viewpoint we discuss some of the advantages and disadvantages of the use of adjuvants, and describe various approaches to their identification.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28548487      PMCID: PMC5798239          DOI: 10.1021/acsinfecdis.7b00071

Source DB:  PubMed          Journal:  ACS Infect Dis        ISSN: 2373-8227            Impact factor:   5.084


  51 in total

Review 1.  Cellular impermeability and uptake of biocides and antibiotics in Gram-positive bacteria and mycobacteria.

Authors:  P A Lambert
Journal:  J Appl Microbiol       Date:  2002       Impact factor: 3.772

2.  Small molecule downregulation of PmrAB reverses lipid A modification and breaks colistin resistance.

Authors:  Tyler L Harris; Roberta J Worthington; Lauren E Hittle; Daniel V Zurawski; Robert K Ernst; Christian Melander
Journal:  ACS Chem Biol       Date:  2013-10-28       Impact factor: 5.100

3.  Antibiotic resistance-the need for global solutions.

Authors:  Ramanan Laxminarayan; Adriano Duse; Chand Wattal; Anita K M Zaidi; Heiman F L Wertheim; Nithima Sumpradit; Erika Vlieghe; Gabriel Levy Hara; Ian M Gould; Herman Goossens; Christina Greko; Anthony D So; Maryam Bigdeli; Göran Tomson; Will Woodhouse; Eva Ombaka; Arturo Quizhpe Peralta; Farah Naz Qamar; Fatima Mir; Sam Kariuki; Zulfiqar A Bhutta; Anthony Coates; Richard Bergstrom; Gerard D Wright; Eric D Brown; Otto Cars
Journal:  Lancet Infect Dis       Date:  2013-11-17       Impact factor: 25.071

4.  Combinations of antibiotics and nonantibiotic drugs enhance antimicrobial efficacy.

Authors:  Linda Ejim; Maya A Farha; Shannon B Falconer; Jan Wildenhain; Brian K Coombes; Mike Tyers; Eric D Brown; Gerard D Wright
Journal:  Nat Chem Biol       Date:  2011-04-24       Impact factor: 15.040

Review 5.  Antibiotics: the changing regulatory and pharmaceutical industry paradigm.

Authors:  Richard Bax; Samantha Green
Journal:  J Antimicrob Chemother       Date:  2015-01-28       Impact factor: 5.790

Review 6.  ESKAPEing the labyrinth of antibacterial discovery.

Authors:  Ruben Tommasi; Dean G Brown; Grant K Walkup; John I Manchester; Alita A Miller
Journal:  Nat Rev Drug Discov       Date:  2015-07-03       Impact factor: 84.694

7.  A Common Platform for Antibiotic Dereplication and Adjuvant Discovery.

Authors:  Georgina Cox; Arthur Sieron; Andrew M King; Gianfranco De Pascale; Andrew C Pawlowski; Kalinka Koteva; Gerard D Wright
Journal:  Cell Chem Biol       Date:  2016-12-22       Impact factor: 8.116

Review 8.  A global call from five countries to collaborate in antibiotic stewardship: united we succeed, divided we might fail.

Authors:  Debra A Goff; Ravina Kullar; Ellie J C Goldstein; Mark Gilchrist; Dilip Nathwani; Allen C Cheng; Kelly A Cairns; Kevin Escandón-Vargas; Maria Virginia Villegas; Adrian Brink; Dena van den Bergh; Marc Mendelson
Journal:  Lancet Infect Dis       Date:  2016-11-18       Impact factor: 25.071

Review 9.  The chemotherapy of tuberculosis: past, present and future.

Authors:  D Mitchison; G Davies
Journal:  Int J Tuberc Lung Dis       Date:  2012-06       Impact factor: 2.373

10.  A forward chemical screen identifies antibiotic adjuvants in Escherichia coli.

Authors:  Patricia L Taylor; Laura Rossi; Gianfranco De Pascale; Gerard D Wright
Journal:  ACS Chem Biol       Date:  2012-06-22       Impact factor: 5.100

View more
  46 in total

Review 1.  Considerations and Caveats in Combating ESKAPE Pathogens against Nosocomial Infections.

Authors:  Yu-Xuan Ma; Chen-Yu Wang; Yuan-Yuan Li; Jing Li; Qian-Qian Wan; Ji-Hua Chen; Franklin R Tay; Li-Na Niu
Journal:  Adv Sci (Weinh)       Date:  2019-12-05       Impact factor: 16.806

2.  Various Evolutionary Trajectories Lead to Loss of the Tobramycin-Potentiating Activity of the Quorum-Sensing Inhibitor Baicalin Hydrate in Burkholderia cenocepacia Biofilms.

Authors:  Andrea Sass; Lisa Slachmuylders; Heleen Van Acker; Ian Vandenbussche; Lisa Ostyn; Mona Bové; Aurélie Crabbé; Laurent R Chiarelli; Silvia Buroni; Filip Van Nieuwerburgh; Emmanuel Abatih; Tom Coenye
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

Review 3.  Methicillin-resistant Staphylococcus aureus (MRSA): antibiotic-resistance and the biofilm phenotype.

Authors:  Kelly M Craft; Johny M Nguyen; Lawrence J Berg; Steven D Townsend
Journal:  Medchemcomm       Date:  2019-03-14       Impact factor: 3.597

Review 4.  The Human Milk Glycome as a Defense Against Infectious Diseases: Rationale, Challenges, and Opportunities.

Authors:  Kelly M Craft; Steven D Townsend
Journal:  ACS Infect Dis       Date:  2017-11-15       Impact factor: 5.084

5.  Design, Synthesis, and Nanostructure-Dependent Antibacterial Activity of Cationic Peptide Amphiphiles.

Authors:  Nathalia Rodrigues de Almeida; Yuchun Han; Jesus Perez; Sydney Kirkpatrick; Yilin Wang; Martin Conda Sheridan
Journal:  ACS Appl Mater Interfaces       Date:  2019-01-10       Impact factor: 9.229

Review 6.  Constructing and deconstructing the bacterial cell wall.

Authors:  Jed F Fisher; Shahriar Mobashery
Journal:  Protein Sci       Date:  2019-11-20       Impact factor: 6.725

7.  Narrow-Spectrum Antibacterial Agents.

Authors:  Roberta J Melander; Daniel V Zurawski; Christian Melander
Journal:  Medchemcomm       Date:  2017-11-06       Impact factor: 3.597

8.  Unconventional Antibacterials and Adjuvants.

Authors:  Mayland Chang; Kiran V Mahasenan; Juan A Hermoso; Shahriar Mobashery
Journal:  Acc Chem Res       Date:  2021-01-29       Impact factor: 22.384

9.  Fluorescence Assessment of the AmpR-Signaling Network of Pseudomonas aeruginosa to Exposure to β-Lactam Antibiotics.

Authors:  David A Dik; Choon Kim; Chinedu S Madukoma; Jed F Fisher; Joshua D Shrout; Shahriar Mobashery
Journal:  ACS Chem Biol       Date:  2020-02-10       Impact factor: 5.100

10.  Two novel synthetic peptides inhibit quorum sensing-dependent biofilm formation and some virulence factors in Pseudomonas aeruginosa PAO1.

Authors:  Mostafa N Taha; Amal E Saafan; A Ahmedy; Eman El Gebaly; Ahmed S Khairalla
Journal:  J Microbiol       Date:  2019-06-27       Impact factor: 3.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.